IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment Nov 3, 2025 04:30PM
IR-MED's Key Clinical and Media Milestones Oct 27, 2025 04:05PM
IR-MED Investor Update Letter - Sept-2025 Sep 16, 2025 04:05PM
IR-Med, Inc (IRME) announces positive interim results from PressureSafe study Jun 23, 2025 08:36AM
IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones Jun 23, 2025 08:30AM


May 5, 2025 08:30AM IR-MED Awarded $500,000 Grant from the Israel Innovation Authority to Advance AI-Powered DiaSafe(TM) Device for Diabetic Foot Ulcer Assessment